PoliticalRepoPoliticalRepo

Bill · HR

H.R. 4101 (119th)

Cancer Drug Parity Act of 2025

Original

referredUnited States· United States Congress· EN

Introduced

24 June 2025

Last action

24 June 2025 · Introduced

Status

Referred to the House Committee on Education and Workforce.

Sponsors

Rep. Grothman, Glenn [R-WI-6], Suzanne Bonamici, Rep. Bilirakis, Gus M. [R-FL-12], Rep. Fitzpatrick, Brian K. [R-PA-1], Joseph Morelle, Doris Matsui, Julia Brownley, Rep. Moore, Gwen [D-WI-4], Donald Davis, Sharice Davids, Joe Wilson, Timothy Kennedy, Kathy Castor, Jamie Raskin, Del. Norton, Eleanor Holmes [D-DC-At Large], Becca Balint, Robert Bresnahan, Rep. Vindman, Eugene Simon [D-VA-7], Deborah Ross, John Garamendi, Chrissy Houlahan, Jonathan Jackson, Herbert Conaway, Andrea Salinas, Janelle Bynum, Rep. Neguse, Joe [D-CO-2], Chris Pappas, Rep. Schmidt, Derek [R-KS-2], Ed Case, William Keating

Subjects

Healthcare

Source updated

21 August 2026

Healthcare

Timeline

  1. 24 June 2025

    Introduced

    Introduced in House

    Source: IntroReferral

  2. 24 June 2025

    Introduced

    Referred to the House Committee on Education and Workforce.

    Source: IntroReferral

  3. 24 June 2025

    Introduced

    Introduced in House

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.

Cancer Drug Parity Act of 2025 — United States — PoliticalRepo